UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000061190
Receipt number R000070025
Scientific Title Efficacy of Oral Care with On-Demand Generated Chlorous Acid Ion Solution (MA-T) in Preventing Ventilator-Associated Pneumonia in Intubated ICU Patients: A Single-Center, Open-Label, Non-Randomized Controlled Trial
Date of disclosure of the study information 2026/04/07
Last modified on 2026/04/07 22:31:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of Oral Care with MA-T in Preventing Ventilator-Associated Pneumonia in Intubated ICU Patients

Acronym

MOUTH-CLEAN study

Scientific Title

Efficacy of Oral Care with On-Demand Generated Chlorous Acid Ion Solution (MA-T) in Preventing Ventilator-Associated Pneumonia in Intubated ICU Patients: A Single-Center, Open-Label, Non-Randomized Controlled Trial

Scientific Title:Acronym

MOUTH-CLEAN study

Region

Japan


Condition

Condition

Intubated patients in the intensive care unit

Classification by specialty

Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether oral care using MA-T reduces the incidence of ventilator-associated pneumonia (VAP) compared with conventional oral care in intubated patients admitted to the ICU

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Ventilator-Associated Pneumonia

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Oral care with conventional oral care kit mouthwash (6 ml) and mouth paste (2 g) for brushing.

Interventions/Control_2

Oral care using MA-T mouthwash (6 ml) and MA-T oral gel (2 g) for brushing, in place of conventional mouthwash and mouth paste.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients intubated and receiving mechanical ventilation

Key exclusion criteria

Patients extubated within 48 hours of intubation
Patients with oral or facial trauma
Patients at risk of oral bleeding due to coagulopathy, oral ulcers, or other conditions that may be exacerbated by frequent oral care
Patients capable of performing oral care independently
Patients with pneumonia as the primary diagnosis at admission

Target sample size

200


Research contact person

Name of lead principal investigator

1st name Momoko
Middle name
Last name Sugimoto

Organization

Tokyo Science University Hospital

Division name

Trauma and Acute Critical Care Center

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan

TEL

03-3813-6111

Email

momoko.sugi@gmail.com


Public contact

Name of contact person

1st name Momoko
Middle name
Last name Sugimoto

Organization

Tokyo Science University Hospital

Division name

Trauma and Acute Critical Care Center

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan

TEL

03-3813-6111

Homepage URL


Email

momoko.sugi@gmail.com


Sponsor or person

Institute

Tokyo Science University Hospital

Institute

Department

Personal name



Funding Source

Organization

Earth Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institute of Science Tokyo Clinical Research Review Board

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan

Tel

03-3813-6111

Email

rinri.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 04 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2026 Year 01 Month 27 Day

Date of IRB

2026 Year 01 Month 27 Day

Anticipated trial start date

2026 Year 03 Month 01 Day

Last follow-up date

2028 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 04 Month 07 Day

Last modified on

2026 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070025